Splenic vein thrombosis
ICD-10 D73.5 · ICD-11 DB98.4

Splenic Vein Thrombosis in Cancer: What to Do When LMWH or DOACs Fail to Achieve Vessel Recanalization

This protocol applies to patients with symptomatic acute splanchnic vein thrombosis associated with cancer in whom standard anticoagulation therapy has not achieved adequate vessel recanalization. It describes the next clinical step after first-line treatment failure.

Clinical Scenario

Symptomatic acute splanchnic vein thrombosis in a patient with cancer, where the first-line anticoagulation course has not achieved the highest possible vessel recanalization.

First-Line Failure Condition

The established first-line approach for cancer-associated acute splanchnic vein thrombosis — LMWH or DOACs — did not achieve the clinical goal of the highest possible vessel recanalization. This protocol addresses what to consider when that goal is not met.

Next-Step Approach (Partial Overview)

For a very narrow, carefully selected subset of patients at specialised centres, a thrombolytic intervention may be considered as the next step. The complete eligibility criteria, selection algorithm, and clinical pathway are available in the full protocol.

Clinical Goal

Achieve the highest possible vessel recanalization.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/jth.14836

In patients with cancer-associated symptomatic acute splanchnic vein thrombosis, we recommend LMWH or DOACs. We suggest LMWH in patients with luminal gastrointestinal cancer, active gastrointestinal mucosal abnormalities, genitourinary cancer at high risk of bleeding, or receiving current systemic therapy with potentially relevant drug-drug interactions with DOACs.

In patients with symptomatic acute splanchnic vein thrombosis we recommend against the routine use of systemic or catheter-directed thrombolysis. We suggest considering the use of thrombolysis in specialized centers for very selected patients such as those with mesenteric or extensive splanchnic vein thrombosis and signs of intestinal ischemia, or those whose conditions deteriorate despite adequate anticoagulant therapy.

Treatment of occlusive or non-occlusive acute splanchnic vein thrombosis aims to prevent intestinal infarction or ischemia, and achieve the highest possible vessel recanalization to reduce splanchnic hypertension and bleeding risk.

View source ↗